Valuation: Viatris Inc.

Market Cap 18.75B 16.06B 15.02B 13.75B 25.81B 1,794B 26.15B 178B 69.22B 901B 70.39B 68.85B 2,980B P/E 2026 *
77.5x
P/E 2027 * 30.8x
Enterprise Value 30.81B 26.39B 24.69B 22.6B 42.42B 2,948B 42.98B 292B 114B 1,481B 116B 113B 4,898B EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.98x
Free-Float
91.44%
Yield 2026 *
3.12%
Yield 2027 * 3.2%
1 day+1.47%
1 week+0.75%
Current month-6.26%
1 month-5.46%
3 months+0.83%
6 months+6.34%
Current year+34.27%
1 week 13.94
Extreme 13.942
14.27
1 month 13.93
Extreme 13.926
15.73
Current year 10.52
Extreme 10.52
15.73
1 year 8.09
Extreme 8.092
15.73
3 years 6.45
Extreme 6.452
15.73
5 years 6.45
Extreme 6.452
15.73
10 years 6.45
Extreme 6.452
15.73
Manager TitleAgeSince
Chief Executive Officer 63 2023-03-31
Director of Finance/CFO 59 2026-05-07
Chief Tech/Sci/R&D Officer - 2023-12-14
Director TitleAgeSince
Director/Board Member 78 2020-11-15
Director/Board Member 78 2020-11-15
Director/Board Member 62 2020-11-15
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%+0.75% - - 18.52B
+0.88%+3.84%+77.96%+129.75% 1,109B
+1.07%+3.11%+51.11%+56.67% 644B
+1.20%+5.64%+26.68%+76.48% 463B
+1.02%+3.67%+43.14%+47.27% 371B
+0.85%+2.97%+24.48%+42.54% 301B
+1.26%+4.54%+2.20%+14.84% 256B
+1.88%+5.14%+48.20%+67.80% 234B
+1.59%+0.87%-12.95%-51.91% 205B
+1.87%+5.78%+23.07%+92.57% 178B
Average +1.31%+3.00%+31.54%+52.89% 417.9B
Weighted average by Cap. +1.14%+3.26%+44.79%+72.24%

Financials

2026 *2027 *
Net sales 14.78B 12.66B 11.85B 10.85B 20.35B 1,414B 20.62B 140B 54.59B 710B 55.51B 54.3B 2,350B 15.03B 12.87B 12.05B 11.03B 20.69B 1,438B 20.97B 142B 55.5B 722B 56.43B 55.2B 2,389B
Net income -27.26M -23.35M -21.85M -20M -37.53M -2.61B -38.03M -258M -101M -1.31B -102M -100M -4.33B 340M 291M 272M 249M 468M 32.52B 474M 3.22B 1.26B 16.34B 1.28B 1.25B 54.03B
Net Debt 12.07B 10.33B 9.67B 8.85B 16.61B 1,154B 16.83B 114B 44.55B 580B 45.3B 44.32B 1,918B 11.08B 9.49B 8.88B 8.13B 15.25B 1,060B 15.46B 105B 40.91B 532B 41.6B 40.69B 1,761B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
26-08-21 €13.94 -2.27% 0
26-08-20 €14.27 +1.47% 0
26-08-19 €14.06 -0.48% 0
26-08-18 €14.13 +1.12% 0
26-08-17 €13.97 +0.33% 0
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
16.32USD
Average target price
18.50USD
Spread / Average Target
+13.36%

Quarterly revenue - Rate of surprise